Hims & Hers Health Comprehensive Income 2020-2024 | HIMS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Hims & Hers Health comprehensive income for 2024 was $-0B, a 161.29% increase from 2023.
Hims & Hers Health comprehensive income for 2023 was $-0B, a 55.23% decline from 2022.
Hims & Hers Health comprehensive income for 2022 was $-0B, a 102.19% increase from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Hims & Hers Health comprehensive income for 2024 was $-0B, a 161.29% increase from 2023.
Hims & Hers Health comprehensive income for 2023 was $-0B, a 55.23% decline from 2022.
Hims & Hers Health comprehensive income for 2022 was $-0B, a 102.19% increase from 2021.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$37.2B
Tempus AI (TEM)	$13.5B
Inspire Medical Systems (INSP)	$5.3B
IRhythm Technologies (IRTC)	$3.5B
Privia Health (PRVA)	$3.1B
Enovis (ENOV)	$2.5B
Clover Health Investments (CLOV)	$2.3B
Azenta (AZTA)	$2.1B
Schrodinger (SDGR)	$1.9B
Omnicell (OMCL)	$1.9B
Phreesia (PHR)	$1.7B
10x Genomics (TXG)	$1.5B
Butterfly Network (BFLY)	$1B
Talkspace (TALK)	$652M
Fulgent Genetics (FLGT)	$531M
Standard BioTools (LAB)	$517M
TruBridge (TBRG)	$426M
Nyxoah SA (NYXH)	$357M
Health Catalyst (HCAT)	$338M
SOPHiA GENETICS SA (SOPH)	$319M
Pulmonx (LUNG)	$262M
American Well (AMWL)	$191M
EUDA Health Holdings (EUDA)	$102M
MDxHealth SA (MDXH)	$88M
P3 Health Partners (PIII)	$77M
111 (YI)	$69M
CareCloud (CCLD)	$63M
HeartBeam (BEAT)	$58M
Outset Medical (OM)	$50M
Zepp Health (ZEPP)	$45M